Evidence map›Paper›PMID 36065732›Full record

ArticleThe Journal of antimicrobial chemotherapy2022

Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.

Didem Torumkuney, Roman Kozlov, Sergey Sidorenko, Praveen Kamble, Margarita Lezhnina, Aleksandr Galushkin, Subhashri Kundu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Didem TorumkuneyGlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Roman KozlovSmolensk State Medical University (SSMU), Krupskaya Str. 28 Smolensk 214019, Russia.
Sergey SidorenkoPediatric Research and Clinical Centre for Infectious Diseases, Professor Popov Str. 9, Russia.
Praveen KambleGlaxoSmithKline, 252, Dr Annie Besant Road, Worli, 400030, Mumbai, India.
Margarita LezhninaGlaxoSmithKline Trading, Leningrad's prospect, 37A, bld. 4, Arcus III, 125167 Moscow, Russia.
Aleksandr GalushkinGlaxoSmithKline Trading, Leningrad's prospect, 37A, bld. 4, Arcus III, 125167 Moscow, Russia.
Subhashri KunduGlaxoSmithKline, 23 Rochester Park, 139234, Singapore.
GlaxoSmithKline (India) · INGlaxoSmithKline (United Kingdom) · GBNorth-Western State Medical University named after I.I. Mechnikov · RUSmolensk State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial reistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action.

objectivesTo review AMR in Russia and any initiatives addressing it. Identifying any areas where more information is required will provide a call to action to minimize any further rise in AMR within Russia and to improve patient outcomes.

methodsNational AMR initiatives, antibiotic use and prescribing, and availability of susceptibility data, in particular for the key community-acquired respiratory tract infection (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines commonly used locally for specific CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) were also reviewed, plus local antibiotic availability. Insights from both a local clinician and a local clinical microbiologist were sought to contextualize this information.

conclusionsRussia launched a national strategy in 2017 to prevent the spread of AMR and the WHO reports that as of 2020-21, it is being implemented and actively monitored. Reports suggest outpatient antibiotic use of antibiotics is high and that non-prescription access and self-medication are very common. Antibiotic susceptibility studies in Russia include PeHASus, a multicentre epidemiological study focusing on susceptibilities of community-acquired respiratory pathogens and international studies such as Survey of Antibiotic Resistance (SOAR), Antimicrobial Testing Leadership and Surveillance (ATLAS) and SENTRY Antimicrobial Surveillance Program. International guidelines are used to support the development of local guidelines in Russia, and for the common CA-RTIs Russian clinicians use of several country-specific local antibiotic prescribing guidelines. A standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Russia, could make guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve patient outcomes.

Indexed as

Community-Acquired InfectionsCOVID-19PneumoniaRespiratory Tract InfectionsAcute DiseaseAnti-Bacterial AgentsHealth Services AccessibilityHumansAnti-Bacterial Agents

Identifiers

PMID36065732
PMCPMC9445848
OpenAlexW4294725156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.